Research Associate
Kalobios
South San Francisco
• Developed Humaneered Antibodies Against Infectious Disease, Autoimmunity, and Cancer o Determined anitgen binding format and optimal concentration of reference chimeric Fab o Compared affinity measurements between murine and chimeric Fab in ELISA and ForteBio kinetic analysis o Purified and quanitified chimeric and humaneered Fab’s via periplasmic fractionation, protein G column purification; FPLC o Coomassie staining and western… Show more • Developed Humaneered Antibodies Against Infectious Disease, Autoimmunity, and Cancer o Determined anitgen binding format and optimal concentration of reference chimeric Fab o Compared affinity measurements between murine and chimeric Fab in ELISA and ForteBio kinetic analysis o Purified and quanitified chimeric and humaneered Fab’s via periplasmic fractionation, protein G column purification; FPLC o Coomassie staining and western analysis o Determined parameters for screening of minimal essential binding specificity determinant (MEBSD) libraries o Screened high affinity binders from MESBD libraries: Colony Lift Binding Assay (CLBA) and competitive ELISA o ForteBio kinetic analysis of variable region library screens o Characterized anti-idiotype antibodies for epitope specificity of pipeline products for clinical studies• Developed Signal-Less Secretion System of Humaneered Fab’s o Molecular cloning of variable regions into signal-less expression vectors o Expression studies using bacterial strains for suppressors of signal sequence defects o Investigated optimal induction conditions for library screens: periplasmic fractionation and western analysis o Sequence alignment and verifications • Design, Develop, and Implement New Antibody Humanizing Technology o Molecular cloning of Fab variable regions into expression vectors o Cassette library cloning of antibody frameworks using human and murine sequences: overlapping PCR o Characterize binding kinetics and specificity of identified Fab bindersPOSTERBebbington, CR, Baer, M, Chang, T Flynn, P, Luehrsen, K, Martinez, D, Sun, A et. al., An Engineered Human Antibody for the Treatment of Pulmonary Pseudomonas aeruginosa Infection. KaloBios Pharmaceuticals Inc. (2006) Show less